Funds holding Reviva Pharmaceuticals Holdings Inc
ISIN US76152G2093 · United States
- Fund holders
- 3
- Of which ETFs
- 0 3 other funds
- Value held
- 85.9K $
- Share of capital
- 0.9 % of 13.1M shares on Aug 13, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 59,608 | 43.5K $ | 0.45 % | as of Mar 31, 2026 ↗ | |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 57,959 | 42.3K $ | 0.00 % | 0.44 % | as of Mar 31, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 105 | 76.6 $ | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
Institutional managers
32 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 793,948 | 579.3K $ | as of Mar 31, 2026 |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 762,236 | 556.2K $ | as of Mar 31, 2026 |
| ARMISTICE CAPITAL, LLC | 592,079 | 432K $ | as of Mar 31, 2026 |
| GSA CAPITAL PARTNERS LLP | 261,898 | 191 $ | as of Mar 31, 2026 |
| EMC Capital Management | 128,915 | 44 $ | as of Dec 31, 2025 |
| Warberg Asset Management LLC | 90,772 | 66.2K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 72,992 | 53.3K $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 43,002 | 31.4K $ | as of Mar 31, 2026 |
| Virtu Financial LLC | 32,905 | 24 $ | as of Mar 31, 2026 |
| STATE STREET CORP | 19,160 | 14K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 18,582 | 13.6K $ | as of Mar 31, 2026 |
| HRT FINANCIAL LP | 18,423 | 13 $ | as of Mar 31, 2026 |
| Castleview Partners, LLC | 15,694 | 11.5K $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 10,715 | 7.8K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 10,469 | 7.6K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 8,530 | 6.2K $ | as of Mar 31, 2026 |
| UBS Group AG | 5,269 | 3.8K $ | as of Mar 31, 2026 |
| GROUP ONE TRADING LLC | 3,109 | 2.3K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 2,193 | 1.6K $ | as of Mar 31, 2026 |
| Sound Income Strategies, LLC | 1,500 | 1.2K $ | as of Mar 31, 2026 |
| OSAIC HOLDINGS, INC. | 1,219 | 889 $ | as of Mar 31, 2026 |
| Larson Financial Group LLC | 833 | 608 $ | as of Mar 31, 2026 |
| TD Waterhouse Canada Inc. | 625 | 498 $ | as of Mar 31, 2026 |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 470 | 343 $ | as of Mar 31, 2026 |
| Purpose Unlimited Inc. | 405 | 288 $ | as of Mar 31, 2026 |
Declared shareholders of Reviva Pharmaceuticals Holdings Inc
There are 3 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Barclays PLC | 5.96 % | 763,579 | as of Mar 31, 2026 · SCHEDULE 13G |
| UBS Group AG | 5.80 % | 746,095 | as of Mar 31, 2026 · SCHEDULE 13G |
| CVI Investments, Inc. and 1 other | 4.90 % | 672,811 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding Reviva Pharmaceuticals Holdings Inc". https://titelia.com/en/stocks/reviva-pharmaceuticals-holdings-inc-US76152G2093